CLSI GP16A2 describes routine urinalysis test procedures that address materials and equipment, macroscopic examinations, clinical analyses, and microscopic evaluations.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
More CLSI standard pdf
CLSI GP31-A
Laboratory Instrument Implementation, Verification, and Maintenance, Approved Guideline, GP31AE
$90.00 $180.00
CLSI I/LA20-A2
Evaluation Methods and Analytical Performance Characteristics of Immunological Assays for Human Immunoglobin E (IgE) Antibodies of Defined Allergen Specificities; Approved Guideline--Second Edition, ILA20A2E
$110.00 $221.24
CLSI QMS03-A3
Training and Competence Assessment; Approved Guideline--Third Edition; QMS03A3E
$149.00 $298.31
CLSI M39-A3
Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline--Third Edition, M39A3
$136.00 $272.19